Codexis, Inc. (CDXS) vs Cardiol Therapeutics Inc. (CRDL)
A side-by-side comparison of Codexis, Inc. and Cardiol Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDXS
Codexis, Inc.
$1.41HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
CRDL
Cardiol Therapeutics Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — CDXS vs CRDL
growth of $100 · dividends reinvested · last 8yCDXS -91.4% (-26.4%/yr)CRDL -64.7% (-12.2%/yr)CRDL compounded faster over this window
CDXS CRDL
CDXS vs CRDL: by the numbers
- •CRDL is the larger company ($153M vs $151M market cap).
- •Both run net losses; CRDL's is the smaller (0.00% vs -39.55% net margin).
Metrics side by side
Valuation
| Metric | CDXS | CRDL |
|---|---|---|
| P/S ratio | 1.95 | N/A |
| P/B ratio | 4.59 | 9.02 |
Profitability
| Metric | CDXS | CRDL |
|---|---|---|
| Gross margin | 83.71% | 0.00% |
| Operating margin | -54.46% | 0.00% |
| Net margin | -39.55% | 0.00% |
| ROE | -93.22% | -155.34% |
| ROIC | -23.41% | -165.56% |
Growth (annualized)
| Metric | CDXS | CRDL |
|---|---|---|
| Revenue CAGR (5Y) | 0.38% | N/A |
| Total return CAGR (5Y) | -44.64% | -18.36% |
Frequently asked
- How have CDXS and CRDL total returns compared?
- Over the past 5 years, CDXS delivered -44.64% and CRDL delivered -18.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.